Biocorrx Inc Stock Other OTC
Equities
US09073C1062
Healthcare Facilities & Services
Financials (USD)
Sales 2022 | 214K | Sales 2023 | 89.16K | Capitalization | 6.75M |
---|---|---|---|---|---|
Net income 2022 | -4M | Net income 2023 | -3M | EV / Sales 2022 | 42.5 x |
Net Debt 2022 | 1.61M | Net Debt 2023 | 1.75M | EV / Sales 2023 | 95.3 x |
P/E ratio 2022 |
-1.61
x | P/E ratio 2023 |
-1.73
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 39.01% |
Managers | Title | Age | Since |
---|---|---|---|
Lourdes Felix
CEO | Chief Executive Officer | 56 | 12-09-30 |
Kent Emry
CHM | Chairman | 55 | 13-09-12 |
Louis Lucido
PSD | President | 75 | 19-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Louis Lucido
PSD | President | 75 | 19-02-28 |
Joe Galligan
BRD | Director/Board Member | 64 | 19-03-31 |
Luisa Ingargiola
BRD | Director/Board Member | 56 | 19-02-28 |
1st Jan change | Capi. | |
---|---|---|
-14.92% | 84.68B | |
+13.30% | 81.12B | |
+11.62% | 29.4B | |
-12.71% | 16.73B | |
-3.06% | 16.36B | |
-2.63% | 14.92B | |
-31.75% | 11.77B | |
-1.42% | 11.72B | |
+27.44% | 11.71B |